» Articles » PMID: 19147588

Genome-wide Promoter Analysis of the SOX4 Transcriptional Network in Prostate Cancer Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 2009 Jan 17
PMID 19147588
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

SOX4 is a critical developmental transcription factor in vertebrates and is required for precise differentiation and proliferation in multiple tissues. In addition, SOX4 is overexpressed in many human malignancies, but the exact role of SOX4 in cancer progression is not well understood. Here, we have identified the direct transcriptional targets of SOX4 using a combination of genome-wide localization chromatin immunoprecipitation-chip analysis and transient overexpression followed by expression profiling in a prostate cancer model cell line. We have also used protein-binding microarrays to derive a novel SOX4-specific position-weight matrix and determined that SOX4 binding sites are enriched in SOX4-bound promoter regions. Direct transcriptional targets of SOX4 include several key cellular regulators, such as EGFR, HSP70, Tenascin C, Frizzled-5, Patched-1, and Delta-like 1. We also show that SOX4 targets 23 transcription factors, such as MLL, FOXA1, ZNF281, and NKX3-1. In addition, SOX4 directly regulates expression of three components of the RNA-induced silencing complex, namely Dicer, Argonaute 1, and RNA Helicase A. These data provide new insights into how SOX4 affects developmental signaling pathways and how these changes may influence cancer progression via regulation of gene networks involved in microRNA processing, transcriptional regulation, the TGFbeta, Wnt, Hedgehog, and Notch pathways, growth factor signaling, and tumor metastasis.

Citing Articles

Landscape of Constitutional Variation in Human Disorders.

Grippa M, Graziano C Genes (Basel). 2024; 15(2).

PMID: 38397148 PMC: 10887744. DOI: 10.3390/genes15020158.


cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.

Gulliver C, Busiau T, Byrne A, Findlay J, Hoffmann R, Baillie G Mol Oncol. 2023; 18(3):707-725.

PMID: 38126155 PMC: 10920091. DOI: 10.1002/1878-0261.13572.


Metabolomic Signatures of Exposure to Nitrate and Trihalomethanes in Drinking Water and Colorectal Cancer Risk in a Spanish Multicentric Study (MCC-Spain).

Alcolea J, Donat-Vargas C, Chatziioannou A, Keski-Rahkonen P, Robinot N, Molina A Environ Sci Technol. 2023; 57(48):19316-19329.

PMID: 37962559 PMC: 11457144. DOI: 10.1021/acs.est.3c05814.


Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival.

Qin C, Li A, Xiao Y, Liu W, Zhai E, Li Q Ann Med. 2023; 55(2):2278619.

PMID: 37939252 PMC: 10653697. DOI: 10.1080/07853890.2023.2278619.


Whole Exome-Wide Association Identifies Rare Variants in Associated with Middle Eastern Papillary Thyroid Carcinoma Risk.

Bu R, Siraj A, Azam S, Iqbal K, Qadri Z, Al-Rasheed M Cancers (Basel). 2023; 15(17).

PMID: 37686511 PMC: 10486701. DOI: 10.3390/cancers15174235.


References
1.
Bulyk M, Huang X, Choo Y, Church G . Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc Natl Acad Sci U S A. 2001; 98(13):7158-63. PMC: 34639. DOI: 10.1073/pnas.111163698. View

2.
Salaun B, Coste I, Rissoan M, Lebecque S, Renno T . TLR3 can directly trigger apoptosis in human cancer cells. J Immunol. 2006; 176(8):4894-901. DOI: 10.4049/jimmunol.176.8.4894. View

3.
McCabe C, Spyropoulos D, Martin D, Moreno C . Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer. Cancer Res. 2008; 68(6):1988-96. PMC: 2584783. DOI: 10.1158/0008-5472.CAN-07-5843. View

4.
Hoser M, Baader S, Bosl M, Ihmer A, Wegner M, Sock E . Prolonged glial expression of Sox4 in the CNS leads to architectural cerebellar defects and ataxia. J Neurosci. 2007; 27(20):5495-505. PMC: 6672350. DOI: 10.1523/JNEUROSCI.1384-07.2007. View

5.
Abate-Shen C, Banach-Petrosky W, Sun X, Economides K, Desai N, Gregg J . Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res. 2003; 63(14):3886-90. View